Physician profile
Scott Brewster
NPI 1447785092
$3,743.52
in general payments reported to CMS, 2019-2025
20 companies · $2,196 in 2025
The $2,196 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.09 · 2022: $96.42 · 2023: $154 · 2024: $1,281 · 2025: $2,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,355 · Travel and Lodging: $908 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.79 |
| Travel and Lodging | $907.75 |
| Education | $368.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,650.93 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder, Gore-Tex Vascular Graft |
| Medtronic, INC. | $545.91 | 2024-2025 | Resolute Onyx |
| Abbott Laboratories | $327.66 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint, Perclose Prostyle |
| Heartflow, INC. | $149.12 | 2024-2025 | |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Abiomed | $129.74 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $124.64 | 2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.80 | 2019-2024 | Lifevest |
| Recor Medical INC | $100.05 | 2025 | Paradise Ultrasound Renal Denervation System |
| Edwards Lifesciences Corporation | $75.20 | 2022 | |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Shockwave Medical, INC | $66.10 | 2025 | |
| Amgen INC. | $54.73 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $39.48 | 2022-2025 | Verquvo |
| Genzyme Corporation | $30.21 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $29.30 | 2023 | Definity |
| Alnylam Pharmaceuticals INC. | $28.42 | 2025 | Amvuttra |
| Pfizer INC. | $24.99 | 2025 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Novartis Pharmaceuticals Corporation | $18.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brewster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.